Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
Eli Lilly and NYSE:LLY |
823,14 B | 23,56% | 6/6 | 34,75% | 10,44% | 36,97% | UP |
|
Johnson & Johnson NYSE:JNJ |
555,64 B | 5,26% | 5/5 | 7,04% | -25,83% | 12,27% | UP |
|
Pfizer NYSE:PFE |
156,54 B | 7,82% | 4/6 | -5,31% | 20,22% | 1,74% | UP |
|
Bristol-Myers Squibb NYSE:BMY |
120,73 B | 1,77% | 5/6 | -0,30% | -1,67% | 8,24% | UP |
|
Vertex Pharmaceuticals NasdaqGS:VRTX |
111,71 B | 13,44% | 6/6 | 6,43% | -1,46% | 27,05% | DOWN |
|
Regeneron Pharmaceuticals NasdaqGS:REGN |
76,93 B | 9,26% | 5/6 | 5,41% | 4,82% | 17,05% | UP |
|
Zoetis NYSE:ZTS |
51,61 B | 9,80% | 6/6 | 7,18% | 45,19% | 18,16% | DOWN |
|
United Therapeutics NasdaqGS:UTHR |
25,13 B | 15,13% | 5/6 | 2,41% | -47,57% | 15,09% | UP |
|
Viatris NasdaqGS:VTRS |
17,32 B | -3,69% | 4/6 | 2,85% | -50,64% | 14,32% | UP |
|
Madrigal Pharmaceuticals NasdaqGS:MDGL |
12,09 B | 0,00% | 2/4 | 0,00% | 0,00% | 22,74% | UP |
|
Catalent NYSE:CTLT |
11,52 B | -5,82% | 2/6 | 27,69% | -22,42% | 0,03% | UP |
|
Cytokinetics NasdaqGS:CYTK |
8,15 B | -1,08% | 1/6 | 4,92% | -44,13% | 41,37% | UP |
|
Balchem NasdaqGS:BCPC |
5,69 B | 8,75% | 6/6 | 8,46% | -1,11% | 14,07% | UP |
|
Indivior Pharmaceuticals NasdaqGS:INDV |
3,99 B | 28,91% | 5/6 | 13,62% | -5,65% | 8,29% | UP |
|
TG Therapeutics NasdaqCM:TGTX |
5,46 B | 63,45% | 3/5 | 33,54% | 92,46% | 24,46% | UP |
|
Corcept Therapeutics NasdaqCM:CORT |
4,93 B | 10,36% | 5/6 | 118,76% | 11,20% | 29,48% | DOWN |
|
Ligand Pharmaceuticals NasdaqGM:LGND |
4,62 B | 7,83% | 5/6 | 3,60% | -70,97% | 6,35% | UP |
|
Supernus Pharmaceuticals NasdaqGM:SUPN |
2,95 B | 2,48% | 3/6 | 8,61% | -30,70% | 26,83% | UP |
|
Soleno Therapeutics NasdaqCM:SLNO |
2,72 B | 0,00% | 3/4 | 0,00% | 0,00% | 0,63% | UP |
|
Nektar Therapeutics NasdaqCM:NKTR |
2,88 B | 65,15% | 4/6 | 74,02% | -627,61% | 31,04% | UP |
